Names | |
---|---|
Preferred IUPAC name
(2E)-3-Methoxy-N-{(1Z)-5-[(3S,6R,8S,11S)-4,6,8-trimethyl-3-(2-methylpropyl)-2,5-dioxo-1-oxa-4-azacycloundecan-11-yl]pent-1-en-1-yl}pent-2-enamide | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C28H48N2O5 | |
Molar mass | 492.701 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Kanamienamides is a complex enol ether containing enamide that is currently undergoing research in regards to its inhibitory activity towards cancer cells. The synthesis of kanamienamide consists of several chemical techniques, including CBS asymmetric reduction, Stork-Zhao-Wittig olefination, Cu-mediated amide coupling with vinyl iodide, Evans asymmetric alkylation, and ring-closing metathesis.[1] Kanamienamide is a natural product found in Moorea bouillonii which is a cyanobacterium.[2]